Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans-Reference-Cited by-同舟云学术

Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans

Published:2021-03-30 Issue:6 Volume:49 Page:420-433
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Taavitsainen Päivi,Prien Olaf,Kähkönen Marja,Niehues Michael,Korjamo Timo,Denner Karsten,Nykänen Pirjo,Vuorela Annamari,Jungmann Natalia A.,von Bühler Clemens-Jeremias,Koskinen Mikko,Zurth Christian,Gieschen Hille^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference14 articles.

1. Measurement of renal function during drug development

2. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

3. Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide;Fizazi;N Engl J Med,2020

4. Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans

5. N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: prediction of in vivo drug-drug interactions;Chemico-Biological Interactions;2024-09

2. Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta‐analysis;British Journal of Clinical Pharmacology;2024-07-11

3. New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact;Expert Opinion on Drug Metabolism & Toxicology;2024-05-22

4. Predicting routes of phase I and II metabolism based on quantum mechanics and machine learning;Xenobiotica;2023-11-15

5. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor—Darolutamide;Clinical Pharmacokinetics;2023-07-17